Abstract
Successful chemotherapy and radiotherapy anti-cancer treatments may result in either tumour suppression or senescence induction. Until recently, experts agreed that senescence was a condition of durable growth arrest, promoting it as a favourable therapeutic outcome. However, recent advancements in oncology research evidence senescence as one of the culprits of cancer relapse [1]. Senescence is a complex phenotype, and no specific marker exists, so that multiple assays are required. A solution for fast, non-invasive, and label-free detection of therapy-induced senescent cells comes from nonlinear optical (NLO) microscopy.
© 2023 IEEE
PDF ArticleMore Like This
Arianna Bresci, Francesco Manetti, Silvia Ghislanzoni, Benedetta Talone, Federico Vernuccio, Alejandro De la Cadena, Chiara Ceconello, Renzo Vanna, Giulio Cerullo, Italia Bongarzone, and Dario Polli
M4A.4 International Conference on Ultrafast Phenomena (UP) 2022
Arianna Bresci, Francesco Manetti, Silvia Ghislanzoni, Federico Vernuccio, Salvatore Sorrentino, Chiara Ceconello, Renzo Vanna, Italia Bongarzone, Giulio Cerullo, and Dario Polli
cl_6_1 The European Conference on Lasers and Electro-Optics (CLEO/Europe) 2023
Arianna Bresci, Francesco Manetti, Silvia Ghislanzoni, Federico Vernuccio, Salvatore Sorrentino, Chiara Ceconello, Renzo Vanna, Italia Bongarzone, Giulio Cerullo, and Dario Polli
126271S European Conference on Biomedical Optics (ECBO) 2023